Collection 24 April 2019

CGT 25th Anniversary Collection

To celebrate 25 years of Cancer Gene Therapy, the Editor-in-Chief has selected 25 of the journal's most innovative papers to highlight the journal's impact in the fields of cancer and genetics over the past 25 years.

Content

T-bet promotes potent antitumor activity of CD4⁺ CAR T cells
- Albert T Gacerez
- Charles L Sentman
ArticleOpen Access7 Mar 2018 Cancer Gene Therapy
Obstruction of BRAF^V600E transcription by complementary PNA oligomers as a means to inhibit BRAF-mutant melanoma growth
- J H Rothman
- O Surriga
- G K Schwartz
Original Article22 Sep 2017 Cancer Gene Therapy
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
- L Saadatpour
- E Fadaee
- H Mirzaei
Review11 Nov 2016 Cancer Gene Therapy
Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach
- R Nedaeinia
- M Sharifi
- R Salehi
Original Article1 Jul 2016 Cancer Gene Therapy
Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery
- S C Katz
- G R Point
- R P Junghans
Original Article15 Apr 2016 Cancer Gene Therapy
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance
- M Dietel
- K Jöhrens
- I Anagnostopoulos
Review11 Sep 2015 Cancer Gene Therapy
Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP₃
- R Gan
- Y Yang
- Q H Meng
Original Article13 Jun 2014 Cancer Gene Therapy
Towards a commercial process for the manufacture of genetically modified T cells for therapy
- A D Kaiser
- M Assenmacher
- B Dropulic
ReviewOpen Access23 Jan 2015 Cancer Gene Therapy
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy
- E R Camp
- C Wang
- D K Watson
Original Article8 Mar 2013 Cancer Gene Therapy
Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer
- V J Findlay
- C Wang
- E R Camp
Review2 May 2014 Cancer Gene Therapy
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia
- L-N Zhang
- J-Y Li
- W Xu
Review23 Nov 2012 Cancer Gene Therapy
Nanovector delivery of siRNA for cancer therapy
- H Shen
- T Sun
- M Ferrari
Review4 May 2012 Cancer Gene Therapy
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
- I Goldstein
- V Marcel
- P Hainaut
Review22 Oct 2010 Cancer Gene Therapy
MicroRNA and drug resistance
- J Ma
- C Dong
- C Ji
Review14 May 2010 Cancer Gene Therapy
MicroRNA profile analysis of human prostate cancers
- A W Tong
- P Fulgham
- J Nemunaitis
Original Article24 Oct 2008 Cancer Gene Therapy
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
- A W Tong
- J Nemunaitis
Review28 Mar 2008 Cancer Gene Therapy
Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells
- M Kanehira
- H Xin
- Y Saijo
Original Article10 Aug 2007 Cancer Gene Therapy
siRNA-based approaches in cancer therapy
- G R Devi
Review20 Jan 2006 Cancer Gene Therapy
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
- Lidong Zhang
- Bingliang Fang
Review19 Nov 2004 Cancer Gene Therapy
Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells
- Raquel T Lima
- Luís M Martins
- M Helena Vasconcelos
Original Article19 Mar 2004 Cancer Gene Therapy
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients
- John Nemunaitis
- Casey Cunningham
- Mario Sznol
Original Article22 Sep 2003 Cancer Gene Therapy
Oncolytic herpes simplex virus vectors for cancer virotherapy
- Susan Varghese
- Samuel D Rabkin
Review22 Nov 2002 Cancer Gene Therapy
Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy
- Akira Ito
- Masashige Shinkai
- Takeshi Kobayashi
Original Article11 Oct 2001 Cancer Gene Therapy
Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
- Iris E Eder
- Zoran Culig
- Helmut Klocker
Original Article15 Jul 2000 Cancer Gene Therapy
Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
- Michael J Mastrangelo
- Henry C Maguire
- Edmund C Lattime
Original Article2 Nov 1999 Cancer Gene Therapy

CGT 25th Anniversary Collection

Content

T-bet promotes potent antitumor activity of CD4⁺ CAR T cells

Obstruction of BRAF^V600E transcription by complementary PNA oligomers as a means to inhibit BRAF-mutant melanoma growth

Glioblastoma: exosome and microRNA as novel diagnosis biomarkers

Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance

Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP₃

Towards a commercial process for the manufacture of genetically modified T cells for therapy

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy

Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer

A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia

Nanovector delivery of siRNA for cancer therapy

Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies

MicroRNA and drug resistance

MicroRNA profile analysis of human prostate cancers

Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells

siRNA-based approaches in cancer therapy

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

Oncolytic herpes simplex virus vectors for cancer virotherapy

Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy

Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

Search

Quick links